Novartis is on the final straight to approval of its spinal muscular atrophy (SMA) gene therapy Zolgensma in the EU, after getting a recommendation for approval from the CHMP. The positive opinion ...
Novartis’ AveXis unit has said European regulators have approved its Zolgensma (onasemnogene abeparvovec) gene therapy for the rare childhood wasting disease spinal muscular atrophy (SMA), and has ...
Manulife Financial has a diversified portfolio of other solutions, strong credit ratings, recent acquisitions, and an attractive dividend case. Learn more about MFC stock here.
Maximize Market Research's Global Solar Inverter Market Outlook (2025?2032) indicates that the market is set to expand from ...
Leidos Holdings has been on an acquisition spree while also achieving impressive margins and new contract wins. Read why LDOS ...
Maximize Market Research's Global Solar Inverter Market Outlook (2025-2032) indicates that the market is set to expand from ...
Stella Osoba is the Senior Editor of trading and investing at Investopedia. She co-founded and chaired Women in Technical Analysis. She has 15+ years of experience as a financial writer and technical ...
Ashlyn is one of Forbes Home's in-house writers and a former civil engineer-turned content writer with over six years experience. Until recently, Ashlyn focused on creating content for Forbes Home as ...
Meta, TikTok and OnlyFans were just some of the attendees of Liz Kendall and Jess Phillips' roundtable at Whitehall, with X (formerly Twitter) failing to show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results